Direct inhibition by angiotensin II of insulin-dependent glucose transport activity in mammalian skeletal muscle involves a ROS-dependent mechanism

Arch Physiol Biochem. 2010 May;116(2):88-95. doi: 10.3109/13813451003758703.

Abstract

No previous study has investigated how the vaso-constrictive peptide Ang II impacts insulin action in isolated mammalian skeletal muscle. We investigated the molecular actions of Ang II on insulin signalling and glucose transport in skeletal muscle from lean Zucker rats. Soleus strips were incubated with insulin (5 mU/ml) and/or Ang II (500 nM) for 2 hours. Ang II caused significant (p < 0.05) inhibition of insulin-stimulated glucose transport (39%) and decreased phosphorylation of Akt Ser(473) (37%) and glycogen synthase kinase-3beta Ser(9) (42%) without affecting phosphorylation of IRS-1 Ser(307) or p38 MAPK. We used the superoxide dismutase mimetic, tempol (1 mM), to determine if reactive oxygen species (ROS) contribute to Ang II-mediated insulin resistance. Tempol partially reversed (42%) Ang II-induced inhibition of insulin-stimulated glucose transport. These results indicate that Ang II inhibits distal insulin signalling and insulin-stimulated glucose transport in isolated mammalian skeletal muscle, and that this effect is partially mediated by ROS.

Publication types

  • Research Support, N.I.H., Extramural

MeSH terms

  • Angiotensin II / metabolism
  • Angiotensin II / pharmacology*
  • Animals
  • Biological Transport
  • Female
  • Glucose / metabolism
  • Glucose / pharmacology
  • Hypoglycemic Agents / metabolism
  • Hypoglycemic Agents / pharmacology
  • Insulin / metabolism*
  • Insulin / pharmacology
  • MAP Kinase Kinase Kinases
  • Mammals / metabolism
  • Muscle, Skeletal / drug effects
  • Muscle, Skeletal / metabolism
  • Phosphorylation / drug effects
  • Proto-Oncogene Proteins
  • Proto-Oncogene Proteins c-akt / metabolism
  • Rats
  • Rats, Zucker
  • Reactive Oxygen Species / metabolism*
  • Reactive Oxygen Species / pharmacology
  • Signal Transduction / drug effects
  • p38 Mitogen-Activated Protein Kinases / metabolism
  • p38 Mitogen-Activated Protein Kinases / pharmacology

Substances

  • Hypoglycemic Agents
  • Insulin
  • Proto-Oncogene Proteins
  • Reactive Oxygen Species
  • Angiotensin II
  • Proto-Oncogene Proteins c-akt
  • p38 Mitogen-Activated Protein Kinases
  • MAP Kinase Kinase Kinases
  • MAP3K8 protein, human
  • Glucose